Ballentine Partners’s Pfizer PFE Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $2.05M | Sell |
84,928
-18,852
| -18% | -$493K | 0.03% | 216 |
|
|
2026
Q1 | $2.91M | Buy |
103,780
+4,456
| +4% | +$119K | 0.04% | 154 |
|
|
2025
Q4 | $2.47M | Buy |
99,324
+9,425
| +10% | +$238K | 0.03% | 166 |
|
|
2025
Q3 | $2.29M | Sell |
89,899
-3,329
| -4% | -$82.2K | 0.03% | 176 |
|
|
2025
Q2 | $2.26M | Buy |
93,228
+458
| +0.5% | +$10.7K | 0.03% | 177 |
|
|
2025
Q1 | $2.35M | Sell |
92,770
-11,718
| -11% | -$307K | 0.04% | 165 |
|
|
2024
Q4 | $2.77M | Sell |
104,488
-4,373
| -4% | -$119K | 0.05% | 136 |
|
|
2024
Q3 | $3.15M | Buy |
108,861
+1,172
| +1% | +$34.2K | 0.05% | 121 |
|
|
2024
Q2 | $3.01M | Sell |
107,689
-7,275
| -6% | -$200K | 0.06% | 116 |
|
|
2024
Q1 | $3.19M | Buy |
114,964
+28,589
| +33% | +$793K | 0.06% | 107 |
|
|
2023
Q4 | $2.49M | Sell |
86,375
-14,434
| -14% | -$436K | 0.05% | 124 |
|
|
2023
Q3 | $3.34M | Sell |
100,809
-6,370
| -6% | -$225K | 0.08% | 86 |
|
|
2023
Q2 | $3.93M | Buy |
107,179
+25,837
| +32% | +$1.01M | 0.09% | 78 |
|
|
2023
Q1 | $3.32M | Sell |
81,342
-22,888
| -22% | -$989K | 0.08% | 89 |
|
|
2022
Q4 | $5.34M | Buy |
104,230
+8,593
| +9% | +$412K | 0.16% | 51 |
|
|
2022
Q3 | $4.18M | Buy |
95,637
+3,621
| +4% | +$176K | 0.14% | 55 |
|
|
2022
Q2 | $4.82M | Buy |
92,016
+2,774
| +3% | +$141K | 0.17% | 51 |
|
|
2022
Q1 | $4.62M | Sell |
89,242
-734
| -0.8% | -$38.1K | 0.14% | 52 |
|
|
2021
Q4 | $5.31M | Sell |
89,976
-11,370
| -11% | -$563K | 0.16% | 53 |
|
|
2021
Q3 | $4.36M | Sell |
101,346
-1,348
| -1% | -$59.7K | 0.15% | 51 |
|
|
2021
Q2 | $4.02M | Buy |
102,694
+264
| +0.3% | +$10.3K | 0.14% | 50 |
|
|
2021
Q1 | $3.71M | Sell |
102,430
-16
| -0% | -$568 | 0.14% | 53 |
|
|
2020
Q4 | $3.77M | Sell |
102,446
-9,246
| -8% | -$339K | 0.15% | 49 |
|
|
2020
Q3 | $3.89M | Sell |
111,692
-16,589
| -13% | -$582K | 0.17% | 48 |
|
|
2020
Q2 | $3.98M | Sell |
128,281
-13,854
| -10% | -$471K | 0.19% | 47 |
|
|
2020
Q1 | $4.4M | Sell |
142,135
-30,120
| -17% | -$1.03M | 0.26% | 41 |
|
|
2019
Q4 | $6.4M | Sell |
172,255
-5,655
| -3% | -$201K | 0.29% | 37 |
|
|
2019
Q3 | $6.07M | Sell |
177,910
-3,132
| -2% | -$114K | 0.28% | 38 |
|
|
2019
Q2 | $7.44M | Buy |
181,042
+115,077
| +174% | +$4.57M | 0.36% | 35 |
|
|
2019
Q1 | $2.66M | Sell |
65,965
-3,906
| -6% | -$156K | 0.14% | 63 |
|
|
2018
Q4 | $2.89M | Buy |
69,871
+859
| +1% | +$35.7K | 0.17% | 52 |
|
|
2018
Q3 | $2.88M | Buy |
69,012
+547
| +0.8% | +$21.1K | 0.15% | 58 |
|
|
2018
Q2 | $2.36M | Buy |
68,465
+10,729
| +19% | +$367K | 0.13% | 60 |
|
|
2018
Q1 | $1.95M | Sell |
57,736
-5,793
| -9% | -$199K | 0.11% | 65 |
|
|
2017
Q4 | $2.18M | Sell |
63,529
-366
| -0.6% | -$12.5K | 0.12% | 63 |
|
|
2017
Q3 | $2.16M | Sell |
63,895
-3,277
| -5% | -$105K | 0.12% | 63 |
|
|
2017
Q2 | $2.11M | Buy |
67,172
+30,407
| +83% | +$959K | 0.15% | 66 |
|
|
2017
Q1 | $1.19M | Sell |
36,765
-2,179
| -6% | -$68.7K | 0.08% | 63 |
|
|
2016
Q4 | $1.19M | Sell |
38,944
-34,909
| -47% | -$1.07M | 0.09% | 57 |
|
|
2016
Q3 | $2.37M | Sell |
73,853
-8,452
| -10% | -$283K | 0.19% | 35 |
|
|
2016
Q2 | $2.75M | Sell |
82,305
-15,082
| -15% | -$481K | 0.23% | 35 |
|
|
2016
Q1 | $2.74M | Buy |
97,387
+60,490
| +164% | +$1.73M | 0.24% | 36 |
|
|
2015
Q4 | $1.13M | Buy |
36,897
+432
| +1% | +$13.6K | 0.11% | 46 |
|
|
2015
Q3 | $1.09M | Buy |
36,465
+877
| +2% | +$28.1K | 0.11% | 44 |
|
|
2015
Q2 | $1.13M | Buy |
35,588
+27
| +0.1% | +$880 | 0.11% | 45 |
|
|
2015
Q1 | $1.17M | Buy |
35,561
+459
| +1% | +$14.6K | 0.12% | 42 |
|
|
2014
Q4 | $1.04M | Sell |
35,102
-1,083
| -3% | -$31.1K | 0.12% | 47 |
|
|
2014
Q3 | $1.01M | Sell |
36,185
-142
| -0.4% | -$3.98K | 0.12% | 45 |
|
|
2014
Q2 | $1.02M | Sell |
36,327
-1,254
| -3% | -$35.7K | 0.12% | 45 |
|
|
2014
Q1 | $1.15M | Buy |
37,581
+307
| +0.8% | +$9.15K | 0.13% | 39 |
|
|
2013
Q4 | $1.08M | Buy |
37,274
+748
| +2% | +$21.8K | 0.12% | 46 |
|
|
2013
Q3 | $995K | Sell |
36,526
-15,763
| -30% | -$429K | 0.12% | 46 |
|
|
2013
Q2 | $1.39M | Buy |
+52,289
| New | +$1.44M | 0.19% | 34 |
|
Other funds holding PFE
Ballentine Partners's PFE Position: Q2 2026 in Review
Ballentine Partners reduced its Pfizer (PFE) stake by 18% in Q2 2026, selling an estimated $493K and leaving 84,928 shares worth $2.05M. The position accounts for 0.03% of the portfolio, ranked #216.
Ballentine Partners first reported a position in PFE in Q2 2013 and has held it in 53 quarters since. The position peaked at $7.44M in Q2 2019. 2,823 funds tracked by Wall St. Rank hold PFE as of Q2 2026.
- Ballentine Partners held 84,928 shares of Pfizer worth $2.05M as of Q2 2026.
- Ballentine Partners sold 18,852 Pfizer shares in Q2 2026, an estimated $493K.
- Pfizer made up 0.03% of Ballentine Partners's portfolio in Q2 2026, its #216 holding.
- Ballentine Partners first reported a position in Pfizer in Q2 2013 and has held it in 53 quarters since.
- Ballentine Partners's Pfizer position peaked at $7.44M in Q2 2019.
- 2,823 funds tracked by Wall St. Rank held Pfizer as of Q2 2026.
Based on Ballentine Partners's 13F filing for Q2 2026, filed 17 Jul 2026.